Genitourinary Cancers | Specialty

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research.

Managing Advanced Prostate Cancer in the Future

March 13th 2018

Hereditary Prostate Cancer Testing in Practice

March 13th 2018

Improvements in Detecting and Treating Metastatic CRPC

March 13th 2018

Utilizing AR-Targeted Therapies in CRPC

March 13th 2018

Assessing Treatment Response in M0 CRPC

March 13th 2018

Other Emerging Combination Approaches in RCC

March 13th 2018

AR-Targeted Therapies in CRPC

March 13th 2018

Treatment Goals in M0 CRPC

March 13th 2018

CRPC: Goals of Imaging for the Detection of Metastasis

March 13th 2018

Guidelines for Early Detection of Metastasis in CRPC

March 13th 2018

Treatment Challenges in Nonmetastatic CRPC

March 13th 2018

Detecting Newly Diagnosed Metastatic Prostate Cancer

March 13th 2018

Sequencing Therapy With ADT Combinations

March 13th 2018

Newly Diagnosed Metastatic Prostate Cancer Treatment

March 13th 2018

Risk Stratification in Nonmetastatic Prostate Cancer

March 13th 2018

Challenges Associated With ADT for Prostate Cancer

March 13th 2018

Considerations for Initiating ADT in Prostate Cancer

March 13th 2018

Dr. Bellmunt on PD-L1 Data in Bladder Cancer

March 13th 2018

Joaquim Bellmunt, MD, PhD, associate professor of medicine, Harvard Medical School, director, Bladder Cancer Center, Dana-Farber Cancer Institute, discusses PD-L1 data with pembrolizumab (Keytruda) in patients with bladder cancer.

Dr. Gupta on the Role of Surgery in Bladder Cancer

March 12th 2018

Amit Gupta, MD, urologic oncologist, Department of Surgery, Cedars-Sinai Medical Center, discusses how the use of immunotherapy agents is altering the role of surgery in bladder cancer and the need for Bacillus Calmette-Guérin (BCG) alternatives.

Cytoreductive Nephrectomy Retains Role in Modern RCC Era

March 10th 2018

James Wysock, MD, discusses the evolution of cytoreductive nephrectomy in renal cell carcinoma.